Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 86101-86150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05886270
Implementation of the Child Housing Assessment for a Safe Environment
NAEnrolling by invitation
300 participants
Started: Jun 24, 2022 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT04630730
Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC
PHASE2Active, not recruiting
46 participants
Started: Jun 24, 2022 · Completed: Jun 30, 2030
1 condition1 sponsor10 locations
NCT05274048
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
PHASE1Recruiting
18 participants
Started: Jun 24, 2022 · Completed: Jun 30, 2027
3 conditions3 sponsors3 locations
NCT05400733
Prandial Metabolic Phenotype in Adults
NARecruiting
50 participants
Started: Jun 24, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05388929
Methocarbamol in Ventral and Inguinal HR
PHASE4Active, not recruiting
164 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05405166
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
PHASE3Active, not recruiting
531 participants
Started: Jun 23, 2022 · Completed: Mar 23, 2027
1 condition1 sponsor146 locations
NCT05023993
The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer
NAActive, not recruiting
20 participants
Started: Jun 23, 2022 · Completed: Oct 7, 2025
3 conditions2 sponsors1 location
NCT05403177
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
N/ARecruiting
500 participants
Started: Jun 23, 2022 · Completed: Oct 31, 2026
12 conditions7 sponsors3 locations
NCT06267742
Clinical Trial to Evaluate MDW for Early Detection of Sepsis
N/AActive, not recruiting
2,200 participants
Started: Jun 23, 2022 · Completed: Sep 30, 2026
1 condition4 sponsors3 locations
NCT05464433
Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma
PHASE1/PHASE2Active, not recruiting
46 participants
Started: Jun 23, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor6 locations
NCT05346354
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
PHASE2/PHASE3Recruiting
12 participants
Started: Jun 23, 2022 · Completed: Jan 2, 2029
1 condition1 sponsor21 locations
NCT05430035
Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
EARLY_PHASE1Recruiting
10 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2029
1 condition1 sponsor1 location
NCT03642795
Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology)
N/ARecruiting
150 participants
Started: Jun 23, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor4 locations
NCT05226494
Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma
PHASE1Recruiting
34 participants
Started: Jun 23, 2022 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05177679
Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption
NARecruiting
288 participants
Started: Jun 23, 2022 · Completed: Apr 30, 2026
3 conditions3 sponsors1 location
NCT05403450
A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)
PHASE1/PHASE2Active, not recruiting
33 participants
Started: Jun 23, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor46 locations
NCT05436093
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
NARecruiting
15 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05085028
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE3Recruiting
1,750 participants
Started: Jun 23, 2022 · Completed: May 31, 2027
1 condition4 sponsors37 locations
NCT05040204
The Effects of Dietary Supplementation on Serum Protein Glycosylation
PHASE1Recruiting
44 participants
Started: Jun 23, 2022 · Completed: Sep 1, 2025
1 condition3 sponsors1 location
NCT05542511
Host Blood RNA Signatures for Diagnosis of TB
N/AActive, not recruiting
1,458 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04786821
Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
NARecruiting
24 participants
Started: Jun 23, 2022 · Completed: Oct 30, 2024
6 conditions1 sponsor1 location
NCT05324280
Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain
NARecruiting
68 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06082661
Blood Collection for COM/BSBS
N/ARecruiting
5,000 participants
Started: Jun 23, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04113382
Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy
PHASE1/PHASE2Recruiting
30 participants
Started: Jun 23, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor5 locations
NCT04975997
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
PHASE3Active, not recruiting
864 participants
Started: Jun 23, 2022 · Completed: Jun 25, 2032
1 condition1 sponsor259 locations
NCT05327647
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
PHASE2Recruiting
160 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors7 locations
NCT05479123
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
PHASE4Recruiting
174 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05062291
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
N/ARecruiting
500 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2027
2 conditions1 sponsor40 locations
NCT05378204
Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.
NARecruiting
120 participants
Started: Jun 23, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors25 locations
NCT05457985
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
NARecruiting
430 participants
Started: Jun 23, 2022 · Completed: May 31, 2026
1 condition2 sponsors13 locations
NCT04530123
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
PHASE2Active, not recruiting
102 participants
Started: Jun 23, 2022 · Completed: Jan 19, 2026
1 condition1 sponsor48 locations
NCT05257824
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
PHASE4Active, not recruiting
528 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2026
2 conditions9 sponsors8 locations
NCT05592639
VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer
NAActive, not recruiting
50 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2025
3 conditions4 sponsors1 location
NCT05489575
CPAP for the Treatment of Supine Hypertension
NARecruiting
59 participants
Started: Jun 23, 2022 · Completed: Aug 31, 2026
6 conditions2 sponsors1 location
NCT05349227
Comprehensive Outcomes for After Cancer Health
NARecruiting
625 participants
Started: Jun 23, 2022 · Completed: May 31, 2027
11 conditions12 sponsors7 locations
NCT05379166
Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome
PHASE2Active, not recruiting
32 participants
Started: Jun 23, 2022 · Completed: Oct 15, 2025
2 conditions1 sponsor3 locations
NCT05521438
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
PHASE2/PHASE3Recruiting
30 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05237453
Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer
NARecruiting
30 participants
Started: Jun 23, 2022 · Completed: Mar 1, 2027
1 condition4 sponsors3 locations
NCT05440825
Self-management of Stress and Sleep Disturbances with Virtual Reality Relaxation
NARecruiting
171 participants
Started: Jun 23, 2022 · Completed: Sep 30, 2026
1 condition3 sponsors5 locations
NCT05413057
An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
N/ARecruiting
20,000 participants
Started: Jun 23, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05126355
Effectiveness of the On the Move Group Exercise Program to Improve Mobility in Community-dwelling Older Adults
NAActive, not recruiting
502 participants
Started: Jun 23, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT04987645
Impact of Water Assisted Colonoscopy vs Air Insufflation on Resident Training
NAEnrolling by invitation
140 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05374005
The Impact of Excessive Dietary Sodium on Brain Health
N/ARecruiting
220 participants
Started: Jun 22, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06302634
Cardio-Oncology Rehabilitation Care Process
N/ARecruiting
300 participants
Started: Jun 22, 2022 · Completed: Jun 22, 2027
4 conditions1 sponsor1 location
NCT05350527
Impact of Video Information Support on Preoperative Anxiety in Breast Cancer Surgery
NARecruiting
200 participants
Started: Jun 22, 2022 · Completed: Apr 1, 2026
1 condition2 sponsors4 locations
NCT05236114
GEMINI-NSCLC: NSCLC Biomarker Study
N/ARecruiting
1,200 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2029
1 condition2 sponsors57 locations
NCT05858307
Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements
N/ARecruiting
300 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT06956157
NAC for Treatment-Resistant OCD and Other Related Disorders
PHASE4Active, not recruiting
90 participants
Started: Jun 22, 2022 · Completed: Nov 13, 2025
1 condition1 sponsor1 location
NCT04829136
Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies
NARecruiting
30 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05609786
Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya
NARecruiting
400 participants
Started: Jun 22, 2022 · Completed: Oct 31, 2025
3 conditions2 sponsors1 location